|
ATS News
|
Please continue to check back for more questions and answers.
If you have a question you'd like answered, just ask!
| Saporin Clearance | Targeting Trends, Q4-2008 |
| Apoptosis or Necrosis? | Targeting Trends, Q3-2008 .. |
| Cytotoxicity Assays | Targeting Trends, Q2-2008 |
| Secondary Conjugates; Reducing Agents | Targeting Trends, Q1-2008 |
| Cost of Targeted Toxin | Targeting Trends, Q4-2007 |
| Disposal, Sterilization, Intrastriatal Administration, and Activation |
Targeting Trends, Q3-2007 |
| Agonist Effects | Targeting Trends, Q2-2007 |
| Targeted Toxin Controls | Targeting Trends, Q1-2007 |
| Anti-DBH-SAP Administration | Targeting Trends, Q4-2006 |
| Retrograde Transport | Targeting Trends, Q2/Q3-2006 .. |
| LPS Content | Targeting Trends, Q1-2006 |
| Dose Ranging | Targeting Trends, Q4-2005 |
| Saporin Safety | Targeting Trends, Q3-2005 |
| Cytotoxicity of Unbound Saporin | Targeting Trends, Q2-2005 |
| Effective Toxins | Targeting Trends, Q4-2004 / Q1-2005 |
| Eliminating CBF Neurons | Targeting Trends, Q3-2004 |
| Streptavidin versus Avidin | Targeting Trends, Q2-2004 |
| Not the Right Stuff | Targeting Trends, Q1-2004 |
| Dosing, Volume, and Animal Care | Targeting Trends, Q3-2003 |
| Retrograde Transport | Targeting Trends, Q2-2003 |
| Custom Peptide-Saporin Conjugates | Targeting Trends, Q1-2003 |
| Custom Antibody-Saporin Conjugates | Targeting Trends, Q4-2002 |
| Neuropeptide Toxins | Targeting Trends, Q3-2002 |
| Toxin Safety | Targeting Trends, Q1/Q2-2002 |
| Time Course of Targeted Toxins | Targeting Trends, Q4-2001 |
| In Vivo Delivery of Targeted Toxins | Targeting Trends Q3-2001 |
| Suicide Transport and Immunolesioning | Targeting Trends Q2-2001 |
| In Vivo Use of Targeted Toxins | Targeting Trends Q1-2001 |
| Second Immunotoxins | Targeting Trends Q4-2000 |
Home | Tutorial | Catalog | News | References | Search | Contact | Site Map
ADVANCED TARGETING SYSTEMS